Longeveron Inc.

Ownership Transactions Reported by 25 Insiders

Symbol
LGVN on Nasdaq
Industry
Pharmaceutical Preparations
Location
1951 Nw 7 Th Avenue, Suite 520, Miami, FL

Insiders trading volume in the past year

Longeveron Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Donald M. Soffer Director $8.76M Dec 21, 2022
Joshua Hare Chief Scientific Officer, Director, 10%+ Owner $1.01M -$7.37K -0.72% Jul 15, 2025
Mohamed Wa'el Ahmed Hashad Chief Executive Officer $564K Jul 15, 2025
Rock Soffer Director $303K -$29.4K -8.85% Jul 15, 2025
Paul T. Lehr General Counsel, Secretary $261K Oct 1, 2025
Kwan-Hong Christopher Min Chief Medical Officer $199K Apr 4, 2022
Lisa Locklear Chief Financial Officer $177K Oct 1, 2025
Geoff Green Ceo $175K Apr 4, 2022
Nataliya Agafonova Chief Medical Officer $168K Oct 1, 2025
Devin Blass CTO & SVP of CMC $157K Oct 1, 2025
James Nathaniel Powell Chief Executive Officer $95.1K Oct 1, 2025
James Clavijo CFO and Treasurer $61.9K Jun 27, 2023
Ursula Ungaro Director $54.9K Jul 15, 2025
Neil E. Hare Director $50.8K Aug 15, 2024
Neha J. Motwani Director $44.2K Jul 15, 2025
Richard N. Kender Director $44.2K Jul 15, 2025
Roger Joseph Hajjar Director $44.2K Jul 15, 2025
Khoso Baluch Director $43.6K -$2.59K -5.6% Aug 11, 2025
George A. Paletta Jr. Director $25.6K Oct 1, 2025
Jeffrey Pfeffer Director $20.3K Dec 28, 2023
Cathy Ross Director $13.1K Jan 10, 2024
Todd Girolamo Director $6.55K Dec 21, 2022
Erin Borger Director Dec 21, 2022
Ds Med Llc 10%+ Owner May 17, 2022
Douglas W. Losordo Director Dec 21, 2023

Recent Insider Transactions by Companies or Individuals for Longeveron Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.